Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Regeneron Pharmaceuticals’ Inmazeb FDA approval: A milestone in Ebola treatment Regeneron Pharmaceuticals has achieved a significant breakthrough with the approval of its antibody cocktail, Inmazeb (atoltivimab, maftivimab, and… bypharmanewsdailyOctober 15, 2020